Clinical trials
Recruiting Phase 2 Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 14 |
| 2025 | 14 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Pulmonary Hospital, Shanghai, China | 3 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 3 |
| National Cancer Institute (NCI) | 2 |
| Puma Biotechnology, Inc. | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Shanghai Chest Hospital | 2 |
| Sun Yat-sen University | 2 |
| AHS Cancer Control Alberta | 1 |
| AIO-Studien-gGmbH | 1 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 59 |
| Lung Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Thoracic Neoplasms | 3 |
| Brain Neoplasms | 2 |
| Lung Diseases | 2 |
| Respiratory Tract Neoplasms | 2 |
| Bronchial Neoplasms | 1 |
| Carcinoma, Bronchogenic | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.